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Abstract 
Myeloid differentiating factor 88 (MyD88) is one of a critical adaptor molecule in 
the Toll-like receptor (TLR) signaling pathway. The TIR domain of MyD88 serves 
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as a protein-protein interaction module and interacts with other TIR-containing 
proteins such as Mal (MyD88 adaptor-like) and Toll-like receptor 4 to form signal 
initiation complexes. Here we report the 15N, 13C, and 1H chemical shift 
assignments of the TIR domain of MyD88. The resonance assignments obtained 
in this work will contribute to the study of heteromeric TIR-TIR interactions 
between MyD88 and TIR-containing receptors or adaptors.  
 
Biological context 
   MyD88 is an essential and universal cytosolic adaptor protein in the signal 
transduction pathways mediated by members of the IL-1 family, including IL-18, 
and the Toll-like receptors (TLRs). It consists of an N-terminal death domain, a 
C-terminal Toll/Interleukin-1 receptor (TIR) domain (~150 amino acid residues), 
and a small linker segment between them. In innate immune responses, MyD88 
plays pivotal roles in bridging between membraneous TLR and downstream 
kinases, such as the IL-1 receptor-associated kinases (IRAKs), in the cytosol 
(O'Neill and Bowie, 2007). For example, in the TLR4 pathway, the cytosolic TIR 
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domain of lipopolysaccharide (LPS)-stimulated TLR4 interacts with the TIR 
domain of MyD88 (MyD88-TIR). Concurrently, the death domain of MyD88 
interacts with the death domain of IRAK4, activating the kinase. This initiates a 
phosphorylation cascade that eventually activates the transcription factors NF-κB 
(nuclear factor κB) and AP-1 (activator protein 1) (Akira et al., 2006). 
 
   The TIR domains serve as protein-protein interaction modules, which are 
conserved in the intracellular region of TLRs and also in cytosolic adaptor 
proteins such as MyD88, Mal (MyD88 adaptor-like), TRIF (TIR domain-containing 
adaptor inducing IFN-β), TRAM (TRIF-related adaptor molecule), and SARM 
(sterile α and HEAT Armadillo motifs). The crystal structures of TIR domains of 
some mammalian membranous receptors (TLR1, TLR2, TLR10, IL-1RAPL) and 
a bacterial protein (Paracoccus denitrificans TIR (PdTIR)) have been reported 
(Chan et al., 2009; Khan et al., 2004; Nyman et al., 2008; Tao et al., 2002; Xu et 
al., 2000), in some of which homomeric TIR interfaces were observed. However, 
the functional relevance of such interactions remains obscure, as the formation of 
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these homo-dimers of TIR domains had not been observed in solution (Khan et 
al., 2004; Nyman et al., 2008).  
 
In our previous study, the isolated MyD88-TIR was shown to exist as a monomer, 
while full-length MyD88 forms a dimer in solution. The dimerization appears to be 
mediated via homomeric interactions within its death domain (Ohnishi et al., 
2009). In that study, we performed NMR titration experiments using 15N 
MyD88-TIR and characterized a functionally relevant heteromeric TIR-TIR 
interaction with another TIR domain derived from Mal, which had been shown to 
enhance LPS-stimulated TLR4 signaling. Interestingly, no interaction has been 
observed between TLR4-TIR and MyD88-TIR, while Mal has been shown to 
directly bind TLR4-TIR. Thus, Mal seems to bridge between TLR4 and MyD88. 
These results exemplified the binding specificity among TIRs and its importance 
in forming correct signal initiation complexes (Ohnishi et al., 2009). 
 
   Here, we describe the NMR assignments of the TIR domain of MyD88. In IL-1R 
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and TLR signaling, the heteromeric TIR interactions of MyD88 play a central role 
in the above-mentioned formation of the TLR signalosome. The resonance 
assignments form a substantial contribution to the study of the heteromeric 
TIR-TIR interactions between MyD88 and TIR containing receptors or adaptors.  
 
Methods and Experiments 
Sample preparation 
The portion of the human MyD88 gene encoding the TIR domain (amino acid 
residues 148-296) was cloned into the vector pGEX-5X-3 digested with 
restriction enzymes, ECORI and NotI (GE Healthcare). This vector was 
transformed into E. coli BL-21 (DE3) (Novagen). The transformed bacterial cells 
were cultured at 37°C until the OD600 reached approximately 0.5. The cells were 
then induced with 1.0 mM IPTG and cultured for 16 hours at 25°C. For 15N-or 
13C,15N-double-labeling, rich growth media containing stable isotope-enriched 
nutrients (Silantes) were used. Harvested bacterial cells were once frozen and 
thawed before the next lysis step. The cells were resuspended in lysis buffer 
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(20mM Tris, pH 8.0, 400mM KCl, 1mM EDTA, 10mM 2-mercaptoethanol and 
protease inhibitors) and disrupted by sonication on ice. The supernatant was 
loaded onto a glutathione Sepharose 4B FF (GE Healthcare) affinity 
chromatography column. Lysis buffer at 30x the bed volume of this resin was 
used for the washing step. GST fused MyD88-TIR protein was eluted with elution 
buffer (50mM Tris, pH 8.0, and 10mM 2-mercaptoethanol, and 10mM reduced 
glutathione). The GST-tag was cleaved by digestion with Factor Xa (1% of total 
protein volume) (Haematologic Technologies Inc.). Subsequently, the TIR 
domain was purified by gel filtration (Sephacryl S-100 HR 26/60 column, GE 
Healthcare) and cation-exchange chromatography (Mono-S column, GE 
Healthcare). The gel filtration running buffer was 20 mM potassium phosphate 
buffer (pH 6.0) containing 100mM KCl, 0.1 mM EDTA and 10 mM DTT. Using this 
purification protocol, 15N-labeled or 13C, 15N-doubly-labeled TIR domain of 
MyD88 wild-type proteins was prepared. The yields of these proteins were 
approximately 1.0 mg from 1 L of rich growth media containing stable 
isotope-enriched nutrients. For preparing samples where selected amino acids 
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were not labeled, proteins were over-expressed by the same method described 
above with a slight modification. The bacterial cells were first cultured in LB 
media and collected 30 min before IPTG induction by centrifugation. The cells 
were resuspended and cultured in 15N-enriched M9 media containing unlabelled 
Gly, Ser and Cys, or Arg alone to a final composition of 100 mg/L for protein 
expression (The details of this protocol will be published elsewhere by Dr. H. 
Hiroaki). To improve the sample solubility and stability, the sample buffer was 
replaced by 20 mM potassium phosphate buffer (pH 6.0) containing 0.1 mM 
EDTA, 10 mM DTT, 50 mM deuterated L-arginine, and 50 mM deuterated 
L-glutamic acid. The final concentrations of the protein samples for typical NMR 
experiments were about 0.3 mM (Golovanov et al., 2004).  
 
NMR spectroscopy 
All NMR spectra were recorded at 25°C on a Bruker DRX500 or Avance800 
spectrometer equipped with a cryogenic probe. For assignment of backbone 1H, 
13C, and 15N resonances, HNCA, HN(CO)CA, HNCACB, CBCA(CO)NH and 3D 
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1H-15N NOESY-HSQC spectra were recorded. For side chain resonance 
assignment, 2D constant-time 1H-13C HSQC, 1H-13C NOESY-HSQC, 
HCCH-TOCSY, CC(CO)NNH and HCC(CO)NNH were recorded. All NMR data 
were processed using NMRPipe (Delaglio et al., 1995), and analyzed using 
Sparky (Goddard and Kneller, 1999). 
 
Assignments and data deposition 
Employment of 50 mM L-arginine and L-glutamic acid in the sample buffer 
significantly improved the solubility of the sample by approximately three fold, 
resulting in significantly enhanced NMR signal intensities. Following a standard 
sequential assignment procedure, 88.6% of the 1HN, 15N resonances of backbone 
amide groups (124 out of the 140 non-Pro residues) were assigned (Fig. 1). In 
addition, 91.3% of Hα (136 out of 149 residues), 93.3% (139 out of 149 residues) 
of 13Cα, and 91.3% (136 out of 149 residues) of 13Cβ resonances were assigned. 
The sequential correlations of the backbone resonances of 195–200, 202, and 
203 were missing. Those residues are involved in the BB-loop region in the 
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structure of MyD88-TIR. Relatively lower {1H}-15N hetero NOE values of amide 
groups at the neighboring residues suggested that the region did not adopt a 
fixed conformation, but had some flexibility (Ohnishi et al., 2009). This might have 
caused NMR signal broadening at the BB-loop residues. Besides those 
above-mentioned residues, Thr-185, Asp-186, Tyr-187, and Arg-188 in the turn 
region were also missing, which could also be due to NMR signal broadening 
caused by local motions. Nevertheless, substantial numbers of side chain 1H and 
13C atoms of those residues have been assigned on the basis of 13C edited 
NOESY and HCCH-TOCSY spectra. The assigned chemical shifts of the TIR 
domain of MyD88 have been deposited in the BMRB database under accession 
number 11078. The coordinates of the TIR domain of human MyD88 have been 
deposited at the Protein Data Bank under accession code 2z5v. 
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Fig. 1 1H, 15N HSQC spectrum of uniformly 15N-labeled TIR domain of human 
MyD88 in 20 mM potassium phosphate buffer (pH 6.0) containing 0.1 mM EDTA, 
10 mM DTT, 50 mM deuterated L-arginine, and 50 mM deuterated L-glutamic 
acid recorded at 25°C.  
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